Where Will Henry Schein Stock Be in 5 Years?
If you’re looking at Henry Schein (NASDAQ: HSIC) and wondering…
Sell
41
NTLA Quote, Financials, Valuation and Earnings
Last price:
$9.17
Seasonality move
:
21.05%
Day range:
$8.93 - $9.23
52-week range:
$5.90 - $28.18
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
20.27x
P/B ratio:
1.22x
Volume:
2.2M
Avg. volume:
3.3M
1-year change:
-63.18%
Market cap:
$948.8M
Revenue:
$57.9M
EPS (TTM):
-$5.23
Earnings Data
Next earnings date for NTLA
Aug 08
2025
Most recent earnings per share
-$1.10
Beat by $0.17
(May 8/2025)
Consensus Estimate
-$1.27
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NTLA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | $12.3M | -- | -- | -$1.03 | -- |
| 05/08/2025 | Q1 | $12M | $16.6M | -$1.10 | -$1.27 | $0.17 |
| 02/27/2025 | Q4 | $8.1M | $12.9M | -$1.27 | -$1.32 | $0.05 |
| 11/07/2024 | Q3 | $7.2M | $9.1M | -$1.34 | -$1.37 | $0.03 |
| 08/08/2024 | Q2 | $18.5M | $7M | -$1.52 | -$1.20 | -$0.32 |
| 05/09/2024 | Q1 | $9.1M | $28.9M | -$1.12 | -$1.36 | $0.24 |
| 02/22/2024 | Q4 | $11.4M | -$1.9M | -$1.46 | -$1.44 | -$0.02 |
| 11/09/2023 | Q3 | -- | -- | -$1.38 | -$1.50 | $0.12 |
| 08/03/2023 | Q2 | -- | -- | -$1.40 | -$1.33 | -$0.07 |
| 05/04/2023 | Q1 | -- | -- | -$1.17 | -$1.38 | $0.21 |
| 02/23/2023 | Q4 | -- | -- | -$1.40 | -$1.37 | -$0.03 |
| 11/03/2022 | Q3 | -- | -- | -$1.49 | -$1.25 | -$0.24 |
| 08/04/2022 | Q2 | -- | -- | -$1.33 | -$1.30 | -$0.03 |
| 05/05/2022 | Q1 | -- | -- | -$1.96 | -$1.11 | -$0.85 |
| 02/24/2022 | Q4 | -- | -- | -$1.09 | -$0.94 | -$0.15 |
| 11/04/2021 | Q3 | -- | -- | -$0.97 | -$0.85 | -$0.12 |
| 08/05/2021 | Q2 | -- | -- | -$1.01 | -$0.61 | -$0.40 |
| 05/06/2021 | Q1 | -- | -- | -$0.69 | -$0.66 | -$0.03 |
| 02/25/2021 | Q4 | -- | -- | -$0.69 | -$0.61 | -$0.08 |
| 11/05/2020 | Q3 | -- | -- | -$0.47 | -$0.57 | $0.10 |
| 08/06/2020 | Q2 | -- | -- | -$0.61 | -$0.67 | $0.06 |
| 05/07/2020 | Q1 | -- | -- | -$0.63 | -$0.47 | -$0.16 |
| 02/27/2020 | Q4 | -- | -- | -$0.58 | -$0.56 | -$0.02 |
| 10/31/2019 | Q3 | -- | -- | -$0.49 | -$0.61 | $0.12 |
| 08/01/2019 | Q2 | -- | -- | -$0.56 | -$0.59 | $0.03 |
| 05/02/2019 | Q1 | -- | -- | -$0.49 | -$0.57 | $0.08 |
| 02/27/2019 | Q4 | -- | -- | -$0.43 | -$0.54 | $0.11 |
| 10/31/2018 | Q3 | -- | -- | -$0.53 | -$0.49 | -$0.04 |
| 08/01/2018 | Q2 | -- | -- | -$0.52 | -$0.56 | $0.04 |
| 05/01/2018 | Q1 | -- | -- | -$0.51 | -$0.56 | $0.05 |
| 03/14/2018 | Q4 | -- | -- | -$0.61 | -$0.45 | -$0.16 |
| 10/31/2017 | Q3 | -- | -- | -$0.44 | -$0.50 | $0.06 |
| 06/30/2017 | Q2 | -- | -- | -$0.45 | -$0.42 | -$0.03 |
| 03/31/2017 | Q1 | -- | -- | -$0.36 | -$0.35 | -$0.01 |
Intellia Therapeutics Earnings Questions
-
How Much did Intellia Therapeutics Generate in Revenue Last Quarter?
Intellia Therapeutics reported $16.6M worth of top line sales in its most recent quarter.
-
Did Intellia Therapeutics Beat Earnings Last Quarter?
Intellia Therapeutics announced earnings per share of -$1.10 which represents a beat of analyst forecast a -$1.27 per share.
-
Is Intellia Therapeutics Profitable?
Intellia Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Intellia Therapeutics EPS Next Year?
Intellia Therapeutics's earnings are forecast to decrease from -$5.25 per share to -$4.20 per share next year representing a decrease of -20.04%.
-
When is Intellia Therapeutics's Earnings Date?
Intellia Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Cisco Stock Forecast: Is It Ready to Surprise Us?
Let’s be real Cisco Systems (NASDAQ: CSCO) hasn’t exactly been…
Where Will Gartner Stock Be in 5 Years?
If you’ve ever wondered what it’s like to invest in…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 45x
Sell
33
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
60
MRUS alert for May 24
Merus NV [MRUS] is up 32.55% over the past day.
Buy
57
RGC alert for May 24
Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.
Buy
90
OKLO alert for May 24
Oklo [OKLO] is up 23.11% over the past day.
